Clinical Trial Update: Telaprevir Open-Label Study in Co-Infected Patients [Phase 3]

View source ↗

Summary

This clinical trial update notes that the open-label Phase 3 study of telaprevir in patients co-infected with hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Telaprevir (telaprevir)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: Hepatitis C, Chronic | Phase 3 | Status: COMPLETED